An Open-label Study of NNZ-2591 in Pediatric Participants With Phelan-McDermid Syndrome

Clinical trial NCT07593391 · RECRUITING

Trial details

NCT number: NCT07593391
Sponsor: Neuren Pharmaceuticals Limited
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Phelan-McDermid Syndrome

Start date: 2026-06-08
Primary completion: 2028-10-29
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.